Today's report was prompted by an article which suggests that the typical medical marijuana patient is "white, educated and employed." Ignoring the insipient racism in that conclusion, I would say that my experience partially supports those findings. Although I found in integrated neighborhoods the clientele at the co-ops was also more mixed; the same was true of my initial physician visit in downtown Oakland, a very integrated city.
The "whiteness" of the users might have more to do with who has access to the entire medical system and also a lot less fear of "the man" in the form of DEA door-kickers. Educated makes sense. The willingness to do some personal research for those unfamiliar with the use of cannabis is a big step in trying medical marijuana. The employed label may only indicate the financial ability to cough up fifteen bucks for a gram of high quality weed.
What is more interesting in the aforementioned study is that patients tend to substitute medical marijuana for prescription medication and/or alcohol. In many ways a potentially safer alternative to NSAIDs, narcotics and booze. In my own case, it was the ineffectiveness of oxycodone that led me to try the pot path.
Next week, my first experimental anomaly.
PRODUCT REPORT: Hash w/ high CBD content
Last week I reported on the CBD measurement and how higher levels might well lower the pot buzz. To that end I purchased a gram of hash with a CBD of 9%, which is more than 4X higher than any other product I have found. Unfortunately, lowering the 'buzz-factor' of hash appears to be about as effective as lowering blue agave tequila from 90 proof to only 80. It still packs a wallop.
Previous posts in this series:
Medical Marijuana (4): Botanical Chemistry
Medical Marijuana (3): Human Experimentation
Medical Marijuana (2): The Dispensary
Medical Marijuana (1): An Inquiry